Sixteen of these (15%) presented with AOI at baseline After 6 mo

Sixteen of these (15%) presented with AOI at baseline. After 6 months therapy 13 patients (81%) resolved AOI while two presented an Hb level reduction. After 6 months therapy we did not find a significant statistical improvement in red blood cell numbers (P = 0.85) and transferrin (P = 0.08) levels. Hb, mean corpuscular volume (MCV), iron, ferritin, C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR) improved reaching statistical significance (P = 0.0002, 0.0001, 0.001, AZD5363 price 0.014; 0.007, 0.004, respectively). Conclusion:  We found 15% frequency of AOI among a selected series of patients with AS. After 6 months of anti-TNFα therapy AOI resolved in the majority of patients

with significant improvement of Hb, MCV, CRP and ESR levels. “
“To evaluate the prevalence and severity of periodontal disease in patients with rheumatoid arthritis (RA) who attended a rheumatology clinic in a university hospital. All consecutive patients with RA who attended the rheumatology clinic between June 2009 and January 2010 were asked to enroll in this buy Dactolisib study. All participants answered questionnaires, which included demographic

data, medical history, medications used and smoking habits. A full mouth periodontal examination, including gingival index, plaque index, probing pocket depth and clinical attachment level was performed. Only cases that had at least 20 teeth were included in this study. Rheumatoid arthritis parameters, including number of tender and swollen joints, erythrocyte sedimentation rate, the presence of rheumatoid factor (RF), hand radiographs, Disease Activity Index (DAS) and health status using the Thai Health Assessment Questionnaire (HAQ), were determined. The association between RA parameters and periodontal condition was examined. There were 196 participants (87.2% female) with a mean age of 51.7 ± 9.70 years, mean disease duration of 9.62 ± 7.0 years and mean DAS score of 4.64 ± 1.25. Eighty-two per cent were RF-positive. Moderate and severe periodontitis were

found in 42% and 57%, respectively. Higher age, male gender, previous or current smoking and high level of plaque score were associated with severe periodontal disease. No differences in RA parameters were found between groups of patients who had moderate and severe periodontitis. We found a high prevalence of periodontitis MycoClean Mycoplasma Removal Kit in Thai patients with RA. However, there was no association between RA parameters and periodontal conditions. “
“Aims:  To describe clinical features of patients with ankylosing spondylitis (AS) from southern and northern China, and investigate the effects of onset age, gender and regional differences on disease phenotype. Methods:  Totally 113 AS patients from southern China and 121 AS patients from northern China were analyzed retrospectively. Results:  In southern and northern groups, low back pain was more frequent among initial symptoms (54.9% vs. 7.7%; 52.4% vs.

As noted in the

As noted in the RAD001 cell line Introduction, the direct evidence available excludes neither possibility because it is clear that Ygf Z dimerizes readily, at least ex vivo (Teplyakov et al., 2004), and that at least some Ygf Z exists with a free thiol inside plant cells (Hägglund et al., 2008). It will not be possible to show definitively whether Ygf Z works as a disulphide-bonded dimer or as a thiol monomer (or both) until the action of Ygf Z can be reconstituted in vitro. However, the balance of present evidence favours the thiol monomer, as summarized

in the following. Firstly, there is reason to suspect that Ygf Z dimer formation is unphysiological. Thus, the three-dimensional structure of the dimer suggests that the intermolecular C228-C228′ disulphide bridge might not be functionally relevant because the dimer interface formed by multiple nonspecific van der Waals interactions is not extensive and contains none of the conserved dodecapeptide motif residues except C228 (Teplyakov et al., 2004). Moreover, in our pilot tests, recombinant Ygf Z isolated from E. coli was 65% monomeric even when no reductants were added (not shown). Secondly, E. coli Ygf Z has been shown to have a

redox-active cysteine, Doramapimod in vitro i.e. a free thiol group, in vivo (Takanishi et al., 2007). Besides C228, Ygf Z has one other cysteine residue, C63, and it was not shown which is the redox-active one (Takanishi et al., 2007). However, the crystal structure places C63 at the C-terminal end of a β-strand in domain B, which makes the sulfhydryl solvent inaccessible, and C228 in an exposed surface loop between two α-helices (α9 and α10) of the Ygf Z monomer (Teplyakov et al., 2004), suggesting that the latter is the redox-active residue. Finally, Ygf Z belongs to the same protein family as sarcosine oxidase, dimethylglycine oxidase and the T-protein of the glycine-cleavage complex. All of these proteins

use tetrahydrofolate to accept a one-carbon (formaldehyde) unit (Teplyakov et al., 2004; Scrutton & Leys, 2005), and the one structurally closest to Ygf Z – the T-protein – acts on a thiol adduct of the one-carbon unit, borne by the H-protein of the complex (Douce et al., 2001). Formaldehyde is a ubiquitous metabolite that spontaneously forms harmful adducts with reactive protein side chains (Metz et al., DCLK1 2004), and it has been proposed that Ygf Z removes such inhibitory adducts from Fe/S enzymes by transferring the formaldehyde moiety to tetrahydrofolate (Waller et al., 2010). In such an enzyme repair mechanism, a cysteine thiol could logically play a go-between role, analogous to that of the active thiol in the glycine-cleavage complex, by binding formaldehyde after its removal from an Fe/S enzyme and before its transfer to tetrahydrofolate. A repair role for Ygf Z is not incompatible with the proposal that Ygf Z facilitates the breakdown of plumbagin (Lin et al.

However, major limitations in the techniques used for the acquisi

However, major limitations in the techniques used for the acquisition and analysis of functional magnetic resonance imaging (fMRI) data have hitherto precluded segregation of function with the amygdala in humans. Here, we used high-resolution fMRI in combination with a region-of-interest-based normalization method to differentiate functionally the contributions of distinct subregions within the human amygdala during two different types of instrumental conditioning: reward and avoidance learning. Through the application of a computational-model-based analysis, we found evidence for a dissociation

between the contributions of the basolateral and centromedial complexes in the representation of specific computational signals during Nivolumab learning, with the basolateral complex contributing more to reward learning, and the centromedial complex more to avoidance learning. These results provide unique insights into the computations being implemented within fine-grained amygdala circuits in the human brain. “
“Cerebellar function is regulated by cholinergic mossy fiber inputs that are primarily derived from the medial vestibular nucleus (MVN) and prepositus hypoglossi Antiinfection Compound Library purchase nucleus (PHN). In contrast to the growing

evidence surrounding cholinergic transmission and its functional significance in the cerebellum, the intrinsic and synaptic properties of cholinergic projection neurons (ChPNs) have not been clarified. In this study, we generated choline acetyltransferase (ChAT)-tdTomato transgenic rats, which specifically express the fluorescent protein tdTomato in cholinergic neurons, and used them to investigate the response properties of ChPNs identified via buy Atezolizumab retrograde labeling using whole-cell recordings in brainstem slices. In response to current pulses, ChPNs exhibited two afterhyperpolarisation (AHP) profiles and three firing patterns; the predominant AHP and firing properties differed between the MVN and PHN. Morphologically, the ChPNs were separated into two types based on their soma size and dendritic extensions. Analyses of the firing responses to time-varying sinusoidal

current stimuli revealed that ChPNs exhibited different firing modes depending on the input frequencies. The maximum frequencies in which each firing mode was observed were different between the neurons that exhibited distinct firing patterns. Analyses of the current responses to the application of neurotransmitter receptor agonists revealed that the ChPNs expressed (i) AMPA- and NMDA-type glutamate receptors, (ii) GABAA and glycine receptors, and (iii) muscarinic and nicotinic acetylcholine receptors. The current responses mediated by these receptors of MVN ChPNs were not different from those of PHN ChPNs. These findings suggest that ChPNs receive various synaptic inputs and encode those inputs appropriately across different frequencies.

In order to avoid disruption of the clinic’s flow, brief post-tes

In order to avoid disruption of the clinic’s flow, brief post-test counselling could be provided after the patient receives the preliminary result and more extensive counselling planned for the next consultation

when the patient find more returns for the confirmation result. Robust links between primary care and HIV specialist services are essential for immediate linkage to care for newly diagnosed patients in order to minimize loss to follow-up. Targeting testing at patients considered to be at high risk of HIV infection in line with World Health Organization (WHO) and the European Centre for Disease Prevention and Control (ECDC) recommendations, as proposed by a majority of the study participants, would make selleck kinase inhibitor implementation cost-effective by reducing the number of tests required. The majority of participating GPs were aware of the existence of rapid HIV tests but did not know how to use them. Specific training in rapid HIV testing should be offered to Spanish GPs. Efforts have to be made to improve training in the provision of pre-test information

and post-test counselling and to improve skills in sexual history taking, in order to identify those patients at risk. Also, GPs should be made aware of missed opportunities for HIV testing and the necessity of their involvement in the early diagnosis of HIV infection. The principal limitations of this study are the opportunistic sampling design of the survey, making the results difficult to generalize to all Spanish GPs, and the low return rate for questionnaires. This response rate is, however, similar to that seen in other surveys of similar study populations and the sample size achieved is greater than in most comparable studies. It is also likely that the GPs who responded are those with a greater interest in HIV/AIDS and hence those most likely to take on board any changes in testing policy likely to have an impact on testing rates. In summary, early

HIV diagnosis and timely linkage to care should be one of the main strategies to both improve the prognosis of HIV-positive triclocarban patients and decrease the incidence of HIV infection in the community. In most settings, primary health care is a frontline service for people with symptoms of acute infection or at risk of HIV infection and other sexually transmitted infections. Our data demonstrate the openness of these professionals to introducing rapid HIV testing into primary health care and moreover identify the main barriers to doing so. According to our results, the introduction of rapid test technology in the primary health sector may be useful in increasing the number of test performed at this level.

(2008) Briefly, 02 mM of DPPH in methanol was mixed with 100 μL

(2008). Briefly, 0.2 mM of DPPH in methanol was mixed with 100 μL of twofold increasing concentrations of sample (1.95–250 μg mL−1) and 50 mM Tris-HCl buffer, pH 7.4. The mixture was shaken vigorously and left at room temperature for 30 min in the dark. The A517 nm was then measured. l-Ascorbic acid was used as a positive control. The free-radical-scavenging activity was then calculated as the Selleckchem Tacrolimus percentage of inhibition according to the following equation: The S07-2 compound was purified to homogeneity and its activity was tested against P. aeruginosa. Data of the purification steps

are summarized in Table 2. Extraction with methanol increased the specific activity to 400 AU mL−1 and led to 100% recovery. The active compound was eluted from a Sep-Pak C18 cartridge at 40% acetonitrile (F40) with a specific activity

of 3200 AU mL−1 and a 64% recovery. F40 was further loaded onto a DEAE-Sepharose column. The S07-2 compound eluted with 10 mM ammonium acetate, pH 3, showed a specific activity of 4000 AU mL−1 and a 40% recovery. To achieve purification, the active fraction was further loaded onto a C18 RP-HPLC column. One major peak was separated from contaminants and subjected to a second HPLC run on a discovery HS PEG column. A single peak was purified to homogeneity (Fig. 1). Its specific activity was increased 3500 times, reaching a value of 7000 AU mL−1. The purity of the S07-2 compound was controlled by TLC as reported in Fig. 1 (see inset). A single spot with Rf 0.7 exhibiting antibacterial INNO-406 mw activity against P. aeruginosa (Fig. 1, inset a) was detected by both UV light at 254 nm and exposure to iodine reagent (Fig. 1, insets b and c, respectively). The optimal temperature and pH values of the

S07-2 compound were also investigated. The compound conserved its antibacterial activity until 90 °C and Pregnenolone lost 50% of its initial activity after autoclaving at 121 °C for 20 min. It was stable in the pH range from 3 to 10 and was resistant to proteases. The S07-2 compound showed a positive reaction with TDM reagent (Fig. 1, inset d), but was negative to ninhydrin. Data indicate the absence of free N-terminal amino group and the presence of peptide bonds. Therefore, the antibacterial compound could be a cyclic peptide antibiotic. A cyclic structure should increase the rigidity of the peptide, reducing its proteolytic degradation by hampering enzyme access to the cleavage sites. Various cyclic peptides containing N- and/or C-terminal blocked residues as well as unusual amino acids have already been described, such as maltacine complex (Hagelin, 2005), subtilosin A lantibiotic (Kawulka et al., 2004), and surfactin, iturin and fengycin lipopeptides (Tamehiro et al., 2002). The molecular mass of the S07-2 compound was determined by matrix-assisted laser desorption/ionization-time-of-flight MS (Fig. 2).

The rate of change in the proportion of LAC PPI, LAC statin and i

The rate of change in the proportion of LAC PPI, LAC statin and ibuprofen and naproxen usage and total dosulepin usage altered significantly following introduction of the NPI. The use of NPIs to influence primary care prescribing in Wales appeared to have varied results. The change in rate of use was significant for four of the nine indicators included in this study. Two of the four promoted medicines associated with a more favourable

risk-benefit profile (percentage ibuprofen and naproxen prescribing and dosulepin use), perhaps suggesting INCB024360 clinical trial that prescribers considered them to be of higher priority. The significant change in rate of LAC statin prescribing was contrary to the aim of this indicator. Although a non-significant prescribing rate change was apparent for the remaining five NPIs, it was possible that 12 months was not sufficient to observe a significant change and that a longer period Nutlin-3a molecular weight of monitoring was required. Ongoing monitoring of these NPIs is the subject of further work.   Generic (%) LAC PPI (%) LAC statin (%) ACE (%) Ibu & Nap

(%) H&A (DDDs/1,000 patients) Dosulepin (DDDs/1,000 PUs) NSAIDs (DDDs/1,000 PUs) PPIs (DDDs/1,000 PUs) *p < 0.05; **p < 0.01 1. All Wales National Prescribing Indicators 2013–2014. All Wales Medicines Strategy Group. http://www.wales.nhs.uk/sites3/Documents/371/National%20Prescribing%20Indicators%202013-2014%20%5Bwebsite%5D.pdf Jose Manuel Serrano Santos, David Wright, Fiona Poland University of East Anglia, Norwich, Norfolk, UK This study aims to explore how Individualised Medication Administration Guides (I-MAGs) would be received and used in care homes for administering medication to patients with dysphagia (PWD). The implementation of I-MAGs could increase nurses’ clinical confidence. Pharmacist interventions in care homes could help standardise practice in medication administration. As conditions such as stroke, cancer, Parkinson's disease and Huntingdon's chorea are commonly found in care homes between 15% and 30% of

residents Adenosine in care homes have been found to have difficulties in swallowing their medicines.(1) To address the difficulties associated with administering medicines to patients who cannot swallow (with dysphagia), Individualised Medication Administration Guides (I-MAGs) were introduced by a specialised pharmacist in Care for Elderly wards in a general hospital in East Anglia. The guides contained detailed information about how to administer each medication and they were individualised to the needs of the patient. The I-MAGs were printed in green forms and attached to the medication chart in order to be used in conjunction with it. The ward nurses reported an increase in their confidence when administering medication when I-MAGs were present in the ward.(2) Some patients with I-MAG were discharged to care homes where the I-MAG might have been equally useful.

In several recent studies, MDR efflux pumps of phytopathogenic ba

In several recent studies, MDR efflux pumps of phytopathogenic bacteria were shown to be involved in the extrusion of plant-derived antimicrobial metabolites, which promotes host colonization and enhances virulence (Martinez et al., 2009, and references therein). Plant-associated soil bacteria

are challenged in several ways, for example by abiotic environmental stresses or competing organisms and their metabolic products. At least conceptually, symbiotic and phytopathogenic bacteria appear to initiate similar programs for invasion and colonization (Soto et al., 2006; Deakin & Broughton, 2009). Therefore, the expression of efflux proteins seems to be a useful common trait of these bacteria that allows them to cope with the toxic Forskolin compounds that they may encounter GKT137831 mw during infection. In this work, we have characterized an RND-type multidrug efflux system, termed BdeAB, in the legume symbiont B. japonicum. Another putative efflux pump, RagCD, was described previously in B. japonicum (Krummenacher & Narberhaus, 2000). However,

ragCD mutants did not differ from the wild type in their antibiotic susceptibility profile and in their symbiotic phenotype. By contrast, we have shown here that the loss of the BdeAB proteins increases the susceptibility toward aminoglycoside antibiotics, supporting the idea that these proteins principally function as a drug efflux pump. Unlike the RmrAB efflux pump of the bean symbiont R. etli, which was shown to be required for nodulation (Gonzalez-Pasayo

& Martinez-Romero, 2000), the B. japonicum bdeAB mutant was not affected in nodule formation. However, soybean nodules elicited by this strain contained fewer bacteroids as compared with nodules formed by the wild type. The impaired colonization by the ΔbdeAB strain might account for the decreased nitrogen-fixation activity in these nodules. It is known that legumes synthesize phytoalexins not only in response to a pathogenic attack but also in the presence of rhizobia Tenofovir concentration (see the review by Baron & Zambryski, 1995, and references therein). In fact, the RmrAB efflux pump confers tolerance to plant-derived antimicrobial compounds (Gonzalez-Pasayo & Martinez-Romero, 2000). Recently, another example of the importance of export proteins in plant–microorganisms interactions was reported. In Mesorhizobium tianshanense, a LysE-family exporter for the antimetabolite canavanine was identified, which helps those rhizobia to survive in a canavanine-rich legume rhizosphere (Cai et al., 2009). It is tempting to speculate that the BdeAB system provides a similar advantage to B. japonicum, perhaps coping with an as yet unidentified soybean-derived compound. The observation that symbiosis of the B.

For women with a plasma VL of 50–399 HIV RNA copies/mL at 36 week

For women with a plasma VL of 50–399 HIV RNA copies/mL at 36 weeks, PLCS should be considered, taking into account the actual VL, trajectory of the VL, length of time on treatment, adherence issues, obstetric factors and the woman’s views. Where the VL is ≥400 HIV RNA copies/mL at 36 weeks, PLCS is recommended. Published cohort data from the UK

and other European countries have shown MTCT rates of <0.5% in women check details with plasma VL <50 HIV RNA copies/mL taking HAART, irrespective of mode of delivery [[1],[4],[25],[26]]. These studies support the practice of recommending planned vaginal delivery for women on HAART with plasma VL <50 HIV RNA copies/mL. Among HIV-positive women taking HAART in pregnancy and delivering between 2000 and 2006 in the UK and Ireland, there was no difference in MTCT rate whether they delivered by planned CS (0.7%; 17 of 2286) or planned vaginal delivery [0.7%; four of 559; adjusted odds ratio (AOR) 1.24; 95% CI 0.34–4.52]. Median VL on HAART was <50 HIV RNA copies/mL (IQR 50–184). MTCT was 0.1% (three transmissions) in 2117 women

on HAART with a delivery VL <50 HIV RNA copies/mL. Two of the three infants were born by elective (pre-labour) CS (0.2%, two of 1135) and one find more by planned vaginal delivery (0.2%, one of 417); two of the three had evidence of in utero transmission (being HIV DNA PCR positive at birth). In this study there were no MTCT data for specific VL thresholds or strata >50 HIV RNA copies/mL plasma, but in the multivariate analysis, controlling for ART, mode of delivery, gestational age and sex, there

was a 2.4-fold increased risk of transmission for every log10 increase in VL, with lack of ART and mode of delivery strongly associated with transmission [1]. Data from the ANRS French Perinatal cohort reported on 5271 women delivering between Amino acid 1997 and 2004 of whom 48% were on HAART. In women on HAART with a delivery VL of <400 copies/mL there was no significant difference in MTCT rates according to mode of delivery, with three of 747 (0.4%) transmission in the ECS group compared with three of 574 (0.5%) transmissions in the vaginal delivery group (P = 0.35). The effect of mode of delivery was also analysed for women delivering with a VL >10 000 HIV RNA copies/mL and no significant protective effect of elective CS was seen (OR 1.46; 0.37–5.80). MTCT was low at 0.4% in women delivering with a VL <50 HIV RNA copies/mL but mode of delivery data for this subset were not provided [4]. In contrast, data from the ECS of 5238 women delivering between 1985 and December 2007 showed that in 960 women delivering with a VL <400 HIV RNA copies/mL, elective CS was associated with an 80% decreased risk of MTCT (AOR 0.2; 95% CI 0.05–0.65) adjusting for HAART and prematurity. There were only two transmissions among 599 women delivering with VLs <50 HIV RNA copies/mL (MTCT 0.

It should be noted, however, that assay comparisons are to be int

It should be noted, however, that assay comparisons are to be interpreted with caution in the absence of a reference gold diagnostic standard. The most relevant analysis is observing how effective an assay is at predicting virological responses to CCR5 antagonist use. Evidence indicates that GTT (performed and interpreted according to defined parameters) is comparable to the original Trofile assay in predicting virological responses to maraviroc in treatment-experienced patients, and comparable to ESTA in predicting

virological responses to maraviroc in treatment-naïve patients [40, 41]. Thus, in the latter group, both ESTA and GTT performed better than the original Trofile in identifying patients who would respond to maraviroc within the MERIT study. An increasing number of prospective cohort studies in both treatment-naïve and treatment-experienced

find more patients starting maraviroc also indicate that GTT is reliable in terms of positive predictive value [42-44]. One advantage of Selleckchem AZD1208 GTT is the ability to circumvent the high plasma viral load requirement of phenotypic assays, and evaluate tropism in virologically suppressed patients using proviral DNA. There is limited evidence to indicate that GTT of proviral DNA may actually provide better concordance with phenotypic tropism prediction than genotypic analysis of plasma [33, 34, 38, 42-46]. Prospective outcome data for the use of proviral DNA, however, are currently limited to case series [23, 43, 44]. There is limited evidence in

support of the notion that, in treated patients, a tropism test result obtained prior to virological suppression remains usually unchanged during suppression [45, 46] and can be used to guide a subsequent treatment switch when viraemia is suppressed. HIV-1 tropism testing should be performed prior to CCR5 antagonist therapy using a validated phenotypic or genotypic method. Genotypic tropism testing offers a more easily accessible, rapid and inexpensive method for tropism diagnostics than phenotypic testing and is therefore the preferred option (Ib). Laboratories undertaking genotypic tropisms testing should do so under quality assurance schemes and according to the prevailing consensus about not preferred methodology for sampling, testing and interpretation (IV). In treatment-naïve patients, tropism testing should be performed immediately prior to the start of therapy whenever CCR5 antagonist use may be considered in the first-line regimen (unlicensed indication in Europe) (Ia). Alternatively a plasma sample could be stored for future testing if required (IV). In treated patients experiencing virological failure, tropism testing should be performed and the results should become available at the same time as those of drug-resistance testing to ensure all available therapeutic options may be considered (Ia). In treated patients with suppressed viraemia for whom a switch to a CCR5 antagonist is considered (e.g.

To improve health interventions targeted at globally mobile popul

To improve health interventions targeted at globally mobile populations, an improved understanding of their health practices is needed. In particular, identifying

sources of health advice and barriers to appropriate pre-travel care is essential. In this study, we surveyed US residents traveling PI3K inhibitors in clinical trials to international destinations who were departing from Boston Logan International Airport in 2009. The purpose was to collect demographic data on travelers, to identify sources of health information, and to understand barriers to the pursuit of health information prior to departure. We surveyed a convenience sample of travelers awaiting departure from Boston Logan International Airport on an international flight or on a domestic flight with an immediate connection to an international flight.

Representatives of the Boston Public Health Commission, the Massachusetts Port Authority, and the Boston Logan Airport Fire Rescue and Police were involved in the development and administration of the Proteasome inhibitor surveys. Surveys were administered from February through August 2009. Survey respondents filled out questionnaires regarding their destination and provided demographic data about themselves and any travel companions. Only one survey was collected per traveling group or family. We questioned individuals as to whether they had pursued health information from specific sources, including check the internet (in particular the CDC Travelers’ Health website), primary care providers, travel medicine specialists, travel agents, employers, and travel publications. We also asked them to indicate whether they were carrying prescription medications related to their trip. The majority of surveys (>90%) were administered in English; surveys were also available in Spanish, Portuguese, French Creole, Chinese, Hindi, and

Arabic. Geographic destinations were classified into income categories according to the 2009 World Bank World Development Report (http://econ.worldbank.org).3 We divided survey respondents into those traveling to countries classified as low and low-middle income (LLMI) or upper-middle and high income (UMHI) by the World Development Report. Travelers were classified as “visiting friends and relatives” (VFR) according to a definition outlined by the US Centers for Disease Control and Prevention (CDC), ie, an immigrant to the United States who returns to his or her homeland, a lower income country, to visit friends or relatives.4 Also included in the VFR category were family members who were born in the United States. Travelers who did not meet the above definition of VFR travel were classified as “visiting family. Survey data were entered and managed in Microsoft Access (Microsoft Corp, Redmond, WA, USA). We performed bivariate and multivariate analyses using SAS 9.2 (SAS, Cary, NC, USA) and SUDAAN 10.